Novo Nordisk partners with Anthropic to use Claude for drug R&D
Novo Nordisk said it has partnered with Anthropic to use Claude models to speed discovery and development of new medicines.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Novo Nordisk partners with Anthropic to use Claude for drug discovery
Novo Nordisk said it is teaming up with Anthropic to deploy the Claude AI model to accelerate development of new medicines.
more on NVO Novo Nordisk: Partners With Anthropic to Advance Drug Discovery and AI-Driven R&D ⠀ · Novo will use Anthropic's Claude models, including Claude Science, for biological reasoning, drug discovery workflows and software engineering. · Initial work will target specific R&D problems where Novo and Anthropic expect AI to accelerate scientific discovery and medicine development. · Collaboration includes defined data governance and human oversight frameworks.
more on NVO Novo Nordisk: Partners With Anthropic to Advance Drug Discovery and AI-Driven R&D ⠀ • Novo will use Anthropic's Claude models, including Claude Science, for biological reasoning, drug discovery workflows and software engineering. • Initial work will target specific R&D problems where Novo and Anth
Novo Nordisk partners with Anthropic to accelerate AI drug discovery
Novo Nordisk and Anthropic formed a collaboration to use Claude Science and frontier models to apply AI to R&D workflows and AI-driven software development, aiming to accelerate discovery of new medicines.